![]() Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases. | ||||
Founding Date | Founding Date 1998 | Founding Date 2018 | Founding Date 2016 | Founding Date 2010 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations Évry-Courcouronnes, FR HQ | Locations Philadelphia, US HQ | Locations Stevenage, GB HQ London, GB Ambler, US | Locations Egkomi, CY HQ |
Employees | Employees 981% increase | Employees 20 | Employees 502% increase | Employees 363% decrease |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 225.5m | Total funding raised $ 205.7m | Total funding raised N/A |

Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.
View company
Gyroscope Therapeutics Holdings is an ophthalmology company.
View companyNIPD Genetics is a biotechnology company that provides genetic testing solutions.
View company